Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammation and Oxidative Stress in Multiple Sclerosis: Consequences for Therapy Development
Valentina Pegoretti, Kathryn A. Swanson, John R. Bethea, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-19
Open Access | Times Cited: 117

Showing 1-25 of 117 citing articles:

Multiple sclerosis progression: time for a new mechanism-driven framework
Tanja Kuhlmann, Marcello Moccia, Timothy Coetzee, et al.
The Lancet Neurology (2022) Vol. 22, Iss. 1, pp. 78-88
Open Access | Times Cited: 327
Mitochondrial dysfunction in neurodegenerative disorders: Potential therapeutic application of mitochondrial transfer to central nervous system-residing cells
Felipe A. Bustamante-Barrientos, Noymar Luque‐Campos, María Jesús Araya, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 69
Free radicals and their impact on health and antioxidant defenses: a review
Nisansala Chandimali, Seon Gyeong Bak, Eun Hyun Park, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 8
Oligodendrocyte Dysfunction in Amyotrophic Lateral Sclerosis: Mechanisms and Therapeutic Perspectives
Stefano Raffaele, Marta Boccazzi, Marta Fumagalli
Cells (2021) Vol. 10, Iss. 3, pp. 565-565
Open Access | Times Cited: 61
Melatonin and multiple sclerosis: antioxidant, anti-inflammatory and immunomodulator mechanism of action
Ana Muñoz-Jurado, Begoña M. Escribano, Javier Caballero‐Villarraso, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 5, pp. 1569-1596
Open Access | Times Cited: 57
The role of oxidative stress in neurodegenerative diseases and potential antioxidant therapies
P Bailo, Elena Llorente Martín, Pilar Calmarza, et al.
Advances in Laboratory Medicine / Avances en Medicina de Laboratorio (2022) Vol. 3, Iss. 4, pp. 342-350
Open Access | Times Cited: 46
From Dysbiosis to Neurodegenerative Diseases through Different Communication Pathways: An Overview
Giorgia Intili, Letizia Paladino, Francesca Rappa, et al.
Biology (2023) Vol. 12, Iss. 2, pp. 195-195
Open Access | Times Cited: 35
Crosstalk between Oxidative Stress and Aging in Neurodegeneration Disorders
Rehab F. Abdelhamid, Seiichi Nagano
Cells (2023) Vol. 12, Iss. 5, pp. 753-753
Open Access | Times Cited: 27
Oxidative stress involvement in the molecular pathogenesis and progression of multiple sclerosis: a literature review
Alfredo Sanabria‐Castro, Alberto Alape‐Girón, Marietta Flores-Dı́az, et al.
Reviews in the Neurosciences (2024) Vol. 35, Iss. 3, pp. 355-371
Closed Access | Times Cited: 10
OxInflammatory Responses in the Wound Healing Process: A Systematic Review
Fernanda Barbosa Lopes, Mariáurea Matias Sarandy, Rômulo Dias Novaes, et al.
Antioxidants (2024) Vol. 13, Iss. 7, pp. 823-823
Open Access | Times Cited: 10
Using Redox Proteomics to Gain New Insights into Neurodegenerative Disease and Protein Modification
Paula Cadenas-Garrido, Ailén Schonvandt-Alarcos, Lourdes Herrera‐Quintana, et al.
Antioxidants (2024) Vol. 13, Iss. 1, pp. 127-127
Open Access | Times Cited: 8
Neural stem cells derived from primitive mesenchymal stem cells reversed disease symptoms and promoted neurogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis
Christina Brown, Christina McKee, Sophia Halassy, et al.
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 42
Human endogenous retroviruses and the inflammatory response: A vicious circle associated with health and illness
Sara Coelho Rangel, Michelly Damasceno da Silva, Amanda Lopes da Silva, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 32
Cannabinoids in the Modulation of Oxidative Signaling
Cristina Pagano, Beatrice Savarese, Laura Coppola, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2513-2513
Open Access | Times Cited: 22
Neuroprotective effect of curcumin against experimental autoimmune encephalomyelitis-induced cognitive and physical impairments in mice: an insight into the role of the AMPK/SIRT1 pathway
Mohamed A. Sadek, Mostafa A. Rabie, Nesrine S. El Sayed, et al.
Inflammopharmacology (2023) Vol. 32, Iss. 2, pp. 1499-1518
Open Access | Times Cited: 18
Exploring the Relationship between Antioxidant Enzymes, Oxidative Stress Markers, and Clinical Profile in Relapsing–Remitting Multiple Sclerosis
Anna Bizoń, Justyna Chojdak-Łukasiewicz, Sławomir Budrewićz, et al.
Antioxidants (2023) Vol. 12, Iss. 8, pp. 1638-1638
Open Access | Times Cited: 16
Quercetin as a possible complementary therapy in multiple sclerosis: Anti-oxidative, anti-inflammatory and remyelination potential properties
Parinaz Javanbakht, Farzane Rezaei Yazdi, Fatemeh Taghizadeh, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21741-e21741
Open Access | Times Cited: 16
Impact of Cognitive Impairment on Quality of Life in Multiple Sclerosis Patients—A Comprehensive Review
Sara Gómez-Melero, Javier Caballero‐Villarraso, Begoña Ma Escribano, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 11, pp. 3321-3321
Open Access | Times Cited: 7
Targeting Vascular Impairment, Neuroinflammation, and Oxidative Stress Dynamics with Whole-Body Cryotherapy in Multiple Sclerosis Treatment
Angela Dziedzic, Karina Maciak, Elżbieta Miller, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3858-3858
Open Access | Times Cited: 6
Withametelin, a novel phytosterol, alleviates neurological symptoms in EAE mouse model of multiple sclerosis via modulation of Nrf2/HO-1 and TLR4/NF-κB signaling
Adnan Khan, Bushra Shal, Ashraf Ullah Khan, et al.
Neurochemistry International (2021) Vol. 151, pp. 105211-105211
Closed Access | Times Cited: 36
Untargeted Metabolomic Profiling of Cuprizone‐Induced Demyelination in Mouse Corpus Callosum by UPLC‐Orbitrap/MS Reveals Potential Metabolic Biomarkers of CNS Demyelination Disorders
Zhijie Zhao, Tongqi Li, Xiaohua Dong, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 34
Bu Shen Yi Sui Capsule Alleviates Neuroinflammation and Demyelination by Promoting Microglia toward M2 Polarization, Which Correlates with Changes in miR‐124 and miR‐155 in Experimental Autoimmune Encephalomyelitis
Zheng Zha, Yan-Fang Gao, Jing Ji, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 33
Astroglial and Microglial Purinergic P2X7 Receptor as a Major Contributor to Neuroinflammation during the Course of Multiple Sclerosis
Marta Sidoryk‐Węgrzynowicz, Lidia Strużyńska
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8404-8404
Open Access | Times Cited: 30
Efficacy of diet on fatigue, quality of life and disability status in multiple sclerosis patients: rapid review and meta-analysis of randomized controlled trials
María Dolores Guerrero Aznar, M Dolores Villanueva Guerrero, Jaime Ramos, et al.
BMC Neurology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 21
Perceived stress in multiple sclerosis patients: Relationship with mood states and pain experience
Mahmoud Abdelwahab Khedr, Heba G. El Sayed, Abeer El Wakil
Multiple Sclerosis and Related Disorders (2022) Vol. 59, pp. 103650-103650
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top